Sessa Capital IM, L.P.'s Net Worth
$0
Estimate Recalculated Nov 7, 2024 11:55AM EST
Who is Sessa Capital IM, L.P.?
Sessa Capital IM, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include COMPX INTERNATIONAL INC, Garrett Motion Inc., Provention Bio, Inc., and SAB Biotherapeutics, Inc..
SEC CIK
Sessa Capital IM, L.P.'s CIK is 0001595849
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COMPX INTERNATIONAL INC (CIX) Snapshot price: $25.43
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Garrett Motion Inc. (GTX) Snapshot price: $7.91
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.63% | -10.00M |
$9.00 | -$90,000,000.00 | 15.24M |
Mar 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +7.37% | 1.73M |
—
|
—
| 25.24M |
Jun 13
| |||
Form 4
| +240.04% | 16.59M |
—
|
—
| 23.5M |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -6.91M |
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Provention Bio, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -15.57M |
—
|
—
|
0
|
Apr 27
| |||
Form 4
| -100.00% | -426.93K |
—
|
—
|
0
|
Apr 20 - Apr 21
| |||
Form 4
| +75.33% | 6.69M |
$15.16 | -$13.68 | 15.57M |
Apr 14
| |||
Form 4
| -25.70% | -3.22M |
—
|
—
| 9.31M |
Mar 31 - Apr 4
| |||
Form 4
| -20.16% | -3.00M |
$9.40 | -$28,200,000.00 | 11.88M |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SAB Biotherapeutics, Inc. (SABS) Snapshot price: $2.9
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.58M |
—
|
—
| 4.58M |
Nov 24
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10 - Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||